General
Preferred name
FURAZOLIDONE
Synonyms
Furoxone ()
Furall ()
Nifurazolidone ()
NSC-6469 ()
P&D ID
PD002325
CAS
67-45-8
Tags
available
drug
Drug Status
experimental
withdrawn
approved
vet_approved
Drug indication
Diarrhea
Antiprotozoal (trichomonas, topical)
Anti-Infective, Topical
Max Phase
Phase 4
First approval
1958
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
2
Compound Sets
17
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugMAP
DrugMAP Approved Drugs
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
25
Properties
(calculated by RDKit )
Molecular Weight
225.04
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
0
Rotatable Bonds
3
Ring Count
2
Aromatic Ring Count
1
cLogP
0.97
TPSA
98.18
Fraction CSP3
0.25
Chiral centers
0.0
Largest ring
5.0
QED
0.43
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
MOA
bacterial DNA intercalator
bacterial DNA inhibitor
Target
DNA
MAO
antibiotic
Bacterial
Parasite
Pathway
Metabolism
Neuroscience
Anti-infection
Apoptosis
Indication
diarrhea, enteritis, cholera
Disease Area
gastroenterology, infectious disease
ATC
G01AX06
Therapeutic Class
Antiinfective Agents
Source data
